Evidence map›Paper›PMID 33204822›Full record

ArticleTransplantation direct2020

A Novel Preservation Solution Containing Quercetin and Sucrose for Porcine Kidney Transplantation.

Mikako Gochi, Fuminori Kato, Asuka Toriumi, Tomoko Kawagoe, Shuichi Yotsuya, Daisuke Ishii, Masahide Otani, Yuji Nishikawa, Hiroyuki Furukawa, Naoto Matsuno

Open access · goldAbstract read
In one paragraph

Article in Transplantation direct, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Pushing the boundaries of innovation: the potential ofFrontiers in cardiovascular medicine · 2023
    Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mikako GochiDepartment of Transplantation Technology and Therapeutic Development, Asahikawa Medical University, Hokkaido, Japan.
Fuminori KatoPharmaceutical Development Division, Life Science Business Development Headquarters, Ishihara Sangyo Kaisha, Ltd., Osaka, Japan.
Asuka ToriumiDepartment of Transplantation Technology and Therapeutic Development, Asahikawa Medical University, Hokkaido, Japan.
Tomoko KawagoePharmaceutical Development Division, Life Science Business Development Headquarters, Ishihara Sangyo Kaisha, Ltd., Osaka, Japan.
Shuichi YotsuyaPharmaceutical Development Division, Life Science Business Development Headquarters, Ishihara Sangyo Kaisha, Ltd., Osaka, Japan.
Daisuke IshiiDepartment of Transplantation Technology and Therapeutic Development, Asahikawa Medical University, Hokkaido, Japan.
Masahide OtaniDepartment of Transplantation Technology and Therapeutic Development, Asahikawa Medical University, Hokkaido, Japan.
Yuji NishikawaDepartment of Pathology, Asahikawa Medical University, Hokkaido, Japan.
Hiroyuki FurukawaDivision of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Asahikawa Medical University, Hokkaido, Japan.
Naoto MatsunoDepartment of Transplantation Technology and Therapeutic Development, Asahikawa Medical University, Hokkaido, Japan.
Asahikawa Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In organ transplantation, the University of Wisconsin (UW) solution has been the gold standard for organ preservation. Quercetin (Que) has numerous antioxidant and anti-inflammatory activities, and sucrose (Suc) may be effective for cold storage (CS). This study aimed to investigate the in vitro protective effect of Que and Suc on cold injury to the kidney and to determine whether Que + Suc could improve ischemia-reperfusion injury during CS and hypothermic oxygenated perfusion (HOPE) in autologous transplantation models.

methodsBHK-21 cells were stored at 4°C for 3 days in UW solution for CS/machine perfusion (CS/MP-UW) with Que (33.1 μM, 3.3 μM, 0.33 μM) and Suc (0.1 M). In a porcine model of renal autologous transplantation, left kidney grafts were preserved under 3 conditions: group 1, CS preservation for 24 hours; group 2, CS preservation for 22 hours and HOPE with CS/MP-UW solution for 2 hours; and group 3, identical preservation as group 2, with Que and Suc added to the solution. Animals were euthanized on day 7 after autologous transplantation.

resultsAfter 3 days of CS preservation, the CS/MP-UW solution with Que (33.1 μM, 3.3 μM) and Suc showed significant cell protection against cold injury. In the porcine model of renal autologous transplantation, the last blood Cre level and the blood lipid hydroperoxide on posttransplantation day 2 were significantly different between group 1 and group 3. Moreover, the total endothelial, glomerular, tubular, interstitial (EGTI) histology score in the kidney tissue was also significantly different. Regarding the change in renal resistance in HOPE, the decrease observed in group 3 was significantly larger than that in group 2.

conclusionsOur results suggest that the addition of Que and Suc to a UW solution can improve kidney preservation and could potentially enhance the outcome of kidney transplantation.

Identifiers

PMID33204822
PMCPMC7665254
OpenAlexW3105849307

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.